Upcoming Webinars
Theranostics – Emerging Trends and Future Direction in Personalized Medicine
Thursday, June 18, 2026 | 12:00 PM – 1:00 PM ET | Sponsored by GE HealthCare
This presentation provides an overview of theranostics as a precision medicine approach that pairs molecular imaging with targeted radioligand therapy to diagnose, treat, and monitor cancer using the same biologic target. It highlights the clinical evolution of theranostics from early radioactive iodine therapy to today’s expanding use of PSMA and neuroendocrine targeted radiopharmaceuticals, emphasizing the rapid growth of clinical indications and therapeutic volume.
The session will also explore major trends shaping the field, including earlier adoption in prostate cancer, a growing pipeline of new targets and isotopes, increasing clinical trial activity and continued investment from pharmaceutical companies. Operational considerations such as advanced PET/CT and SPECT/CT technology, AI-enabled workflow tools, quantitative imaging and scalable infrastructure will also be discussed.
You Will Learn:
- Understand how molecular imaging guides patient specific diagnostics and treatment planning across various disease states
- Review recent innovations in PET/CT and SPECT/CT imaging technologies that improve diagnostic accuracy, workflow efficiency and patient outcomes
- Discuss emerging trends, clinical applications and the evolving role of theranostics in precision medicine, including potential impacts on patient care and healthcare delivery
This webinar is pending CE credit approval.
Pricing:
- AHRA Member: Live attendance and recording is free to members
- Non-Member: Live attendance only is free to non-members
Register
About the Speaker
Jamie Raney
Care Pathway Leader, Theranostics Strategy & Growth, USCAN
Jamie Raney is a seasoned healthcare executive with more than 20 years of experience in nuclear medicine, theranostics and imaging operations. Currently serving as the Care Pathway Leader for Theranostics Strategy and Growth at GE HealthCare, Jamie partners with providers across the U.S. and Canada to enable and optimize cutting edge theranostics programs that elevate patient care and operational efficiency.
Jamie’s career spans leadership roles in both clinical and corporate settings, including Regional Director of Operations at CDL Nuclear Technologies, Director of Imaging and Nuclear Medicine for Rocky Mountain Cancer Centers and Practice Administrator at BAMF Health, where he launched the clinical operations of a state of the art Theranostics Center.
With a strong foundation in nuclear medicine technology and an MBA in Healthcare Management, Jamie brings a unique blend of clinical insight and strategic expertise. He is a Certified Nuclear Medicine Technologist and an active member of the Society of Nuclear Medicine and Molecular Imaging.
Jamie is passionate about advancing theranostics and molecular imaging to improve outcomes for patients and communities. His leadership is marked by a commitment to operational excellence, innovation and collaborative growth.